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RADIATION-INDUCED NEOPLASTIC TRANSFORMATION IN VITRO,
HORMESIS AND RISK ASSESSMENT 
J. Leslie Redpath, PhD, Eugene Elmore, PhD  Department of Radiation
Oncology, University of California Irvine, Irvine, CA
 Dose-response curves for various low-LET radiation sources have consistently been
demonstrated to be J-shaped for the cancer-relevant endpoint of neoplastic transforma-
tion in vitro. Most of these studies have been performed where the radiation has been
delivered at intermediate to high dose-rates (30-3000 mGy/min), where the threshold
dose for induction of neoplastic transformation is around 100-200 mGy. Below these
doses, the transformation frequency is less than that seen spontaneously, indicative of a
hormetic effect. More recently, data have been obtained for low dose rates (<0.5
mGy/min) of low-LET radiation, and again hormetic effects are apparent but with thresh-
old doses now being >1000 mGy. Similar trends have been reported in animal experiments
as well as in human epidemiologic studies. Indeed, the relative risks for induction of neo-
plastic transformation in vitro in the dose range 1 to 1000 mGy agree well with those for
incidence of radiation-induced breast cancer and leukemia in humans. These findings
support the notion that the endpoint of neoplastic transformation in vitro is a plausible
endpoint to not only study mechanisms involved in response to low doses of radiation, but
also to provide information of potential importance to risk assessment.
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RELEVANCE OF IN VITRO ASSAYS 
The in vitro assay of neoplastic transformation has a long history of pro-
viding quantitative and mechanistic data that parallels that found in vivo
(Little 1989). Such findings relate to the effects of dose, dose-rate, radiation
quality, and effects of chemical modifiers and as such are regarded as being
of value to the study of radiation carcinogenesis. This is despite the obvious
microenvironmental limitations and lack of an immune response compared
to the in vivo situation. Another perceived limitation is the refractory nature
of primary human cell cultures to radiation-induced transformation to the
neoplastic phenotype. Even following immortalization, such cells are diffi-
cult to neoplastically transform with radiation and usually require repeated
high radiation doses over a period of time. Such systems are of value in
assessing molecular and cellular characteristics of the radiation-induced
tumorigenic cells but are not suitable for quantitative studies (e.g. Hei et al.
2001). The major workhorse assay in the field of quantitation of radiation-
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induced neoplastic transformation in vitro has been the C3H 10T1/2 mouse
embryo fibroblast system. Another assay that has recently been gaining
wider acceptance is the HeLa x skin fibroblast human hybrid cell assay
(Redpath et al. 1987, Mendonca et al. 1992). This assay has some advan-
tages, both practical and mechanistically, over the C3H 10T1/2 system.
Firstly, the assay takes 21-25 days to go to completion compared to up to 60
days for the C3H 10T1/2 assay. Secondly, the neoplastic phenotype has a cell
surface molecular marker that can be used to identify foci of tumorigenic
cells, as compared to the morphologic changes used with C3H 10T1/2 cells.
Thirdly, the mechanism involved in the neoplastic transformation is the loss
of putative tumor suppressor loci located on chromosomes 11 and 14
(Mendonca et al. 1998). Both the C3H 10T1/2 and the human hybrid cells
should be considered as partway down the pathway from normal to tumori-
genic, i.e. they are preneoplastic. The relevance of use of such cells could
also be questioned. However, since most humans have burdens of preneo-
plastic cells in their body, they could be considered to be a particularly rele-
vant target for carcinogens, including radiation.
ADAPTIVE RESPONSE 
The ability of a low dose of radiation, say 1 to 100 mGy, to ameliorate
the effect of a subsequent high radiation dose, say several Gy, is well
described for a variety of in vitro and in vivo endpoints and has historical-
ly been described as an adaptive response. However, an adaptive response
can also be observed following a low dose exposure alone, without using
a high dose challenge to allow its detection. For example, it is conceivable
that such low-dose responses could impact the shape of dose response
curves at low doses, including for the endpoint of neoplastic transforma-
tion in vitro, where, like for human cancer, there is a certain background
incidence. In addition, such low adapting doses can alter the the latency
period for the appearance of spontaneous tumors in vivo (Mitchel et al.
2003). Mechanistically, adaptive responses have been linked to radiation-
induced protein synthesis, including the upregulation of DNA repair and
cellular antioxidants, (Wolff 1998 and references therein), the promo-
tion of apoptosis (Cregan et al. 1999), and the activation of immunolog-
ical networks (Ina and Sakai 2005a). 
SUPPRESSIVE EFFECTS OF LOW DOSES OF LOW-LET RADIATION FOR
NEOPLASTIC TRANSFORMATION IN VITRO 
Azzam et al. (1996) demonstrated that low doses of 1, 10, and 100
mGy of Co-60 gamma irradiation suppressed the transformation fre-
quency of C3H 10T1/2 cells to levels less than that seen spontaneously.
This was subsequently verified for a dose of 10 mGy of Cs-137 gamma
radiation in the human hybrid cell assay (Redpath and Antoniono 1998).
Full dose-response curves were then developed for a series of low-LET
J. L. Redpath and E. Elmore
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sources including Cs-137 gamma rays, 60 kVp x-rays, 28 kVp x-rays and
232 MeV protons (Redpath et al. 2001, Redpath et al. 2003b, Ko et al.
2004, Elmore et al. 2005, Ko et al. 2006). These dose-response curves
were J-shaped, and consistently demonstrated suppression at low doses
with thresholds between 100 and 200 mGy. These data have now been
combined for analysis. It is realized that while all the data are for low-LET
radiation sources, they are for sources of different energy that potential-
ly have different biological effectiveness. However, even given this limita-
tion, it was felt worthwhile to do a combined analysis to see if the low
dose-suppression seen in individual studies still holds when that data are
combined. Since these experiments were performed over a period of
years using different batches of serum, and since serum batch is well
known to influence background frequency, this combination had to be
done for two groups separated by level (‘low’ and ‘high’) of spontaneous
background frequencies. Details of these analyses are shown in Tables 1
Transformation, hormesis and risk
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TABLE 1. Summary of low background experiments to date on the effect of low doses of low-LET
radiation on the neoplastic transformation of HeLa x skin fibroblast hybrid cells.
No. of No. of Transfor- 95% 
Dose Mean Surviving No. of Flasks mation Confidence
Cohort, Paper Dose Cells No. of Flasks, without Frequency ± SE Intervals 
mGy No.* (mGy) S(×105) Foci N Foci, n (×10–5) (×10–5) (×10–5)
Control 1 0 15.66 73 376 315 4.25 0.54
2 29.32 65 762 699 2.24 0.28
3 35.07 106 1297 1198 2.94 0.30
4 25.44 92 669 582 3.66 0.39
sum 105.49 336.00 3104.00 2794.00 3.10 0.18 2.74, 3.45
1–10 1 5.1 15.41 36 377 346 2.10 0.38
2 25.28 37 708 672 1.46 0.24
3 31.23 28 1173 1148 0.81 0.16
4 11.5 39 287 249 3.54 0.58
sum 83.42 140 2545 2415 1.60 0.14 1.32, 1.88
11–100 2 69.2 16.08 25 426 401 1.60 0.32
3 28.67 63 960 900 2.16 0.28
4 29.64 99 879 781 3.51 0.35
sum 74.39 187 2265 2082 2.57 0.19 2.19, 2.94
101–300 2 226.7 8.62 33 216 188 3.48 0.66
3 8.38 27 288 262 3.25 0.64
4 13.16 54 347 300 3.84 0.56
sum 30.16 114 851 750 3.56 0.35 2.85, 4.27
301–500 2 397.7 11.76 45 288 248 3.66 0.58
3 8.81 44 288 248 4.89 0.77
4 15.71 67 479 421 3.94 0.52
sum 36.28 156 1055 917 4.08 0.35 3.38, 4.77
501–1000 2 850 7.34 47 192 151 6.28 0.98
4 11.8 77 320 260 5.63 0.73
sum 32.48 357 956 713 8.63 0.56 7.52, 9.74
*Paper 1 = Redpath and Antoniono, 1998; Paper 2 = Redpath et al., 2001; Paper 3 = Redpath et
al., 2003; Paper 4 = Ko et al., 2006.
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and 2 and the corresponding dose-response curves are shown in Figure
1. As is shown, the combined data clearly show a hormetic effect with J-
shaped curves for both ‘low’ and ‘high’ background frequencies. The
most significant suppression was apparent for the lowest dose cohort (<10
mGy) for both groups and the threshold was between 100 and 200 mGy
for both groups. It is of importance to note that the suppressive effect of
low doses of low-LET radiation on neoplastic transformation in vitro has
been demonstrated over a wide range of background frequencies from
1.8 × 10–3 (Azzam et al. 1996) to 2.2 × 10–5 (Redpath et al. 2001) and indi-
cates that the hormetic effect is independent of genetic stability of the
target cell population. 
Mechanistic studies indicate that multiple mechanisms are likely
involved in a dose-dependent fashion. These include the upregulation of
DNA repair, and the hyper-radiosensitivity to radiation-induced cell death
of a transformation prone subpopulation (Pant et al. 2003; Redpath,
Short et al. 2003a).
Mathematical modeling of our neoplastic transformation data has
invoked the concept of protective apoptosis-mediated (PAM) death of
cells destined to become neoplastically transformed to account for the
protective effect against neoplastic transformation seen at low doses
(Schoellenberger et al. 2002, Scott et al. 2003, Scott 2005)
Bystander effects due to factors excreted into the extracellular medi-
um do not appear to play a role in this assay although bystander effects as
J. L. Redpath and E. Elmore
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TABLE 2. Summary of high backround experiments to date on the effect of low doses of low-LET
radiation on the neoplastic transformation of HeLa x skin fibroblast hybrid cells.
No. of No. of Transfor- 95% 
Mean Surviving No. of Flasks mation Confidence
Dose Paper Dose Cells No. of Flasks, without Frequency ± SE Intervals 
Cohort No.* (mGy) S(×105) Foci N Foci, n (×10–5) (×10–5) (×10–5)
Control 5 0 25.13 229 672 497 8.07 0.61
6 14.99 152 442 333 8.35 0.80
sum 40.12 381.00 1114.00 830.00 8.17 0.49 7.20, 9.14
5 2.7 28.88 223 900 734 6.35 0.49
6 28.73 253 882 702 7.01 0.52
sum 57.61 476 1782 1436 6.68 0.36 5.96, 7.40
11–100 5 53.7 33.48 243 912 728 6.14 0.45
mGy 6 14.7 164 444 325 9.42 0.87
sum 48.180 407 1356 1053 7.12 0.41 6.30, 7.94
101–300 5 208 37.79 387 978 686 9.18 0.54
mGy 6 13.83 160 444 330 9.53 0.90
sum 51.620 547 1422 1016 9.26 0.46 8.34, 10.18
501–1000 6 600 13.34 233 444 302 12.83 1.08
cGy
sum 13.340 233 444 302 12.83 1.08 10.66, 14.99
*Paper 5 = Ko et al., 2004; Paper 6 = Elmore et al., 2005.
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a consequence of gap junction intracellular communication may do so in
a way which partially offsets effects due to an adaptive response (Ko et al.
2006). Recent low dose-rate studies (Elmore et al 2006) have shown that
the suppressive effects still exist at low doses and the threshold dose is
increased as the dose-rate is decreased.
IN VIVO RESPONSES AT LOW DOSES 
Dose-response curves consistent with a threshold effect have also
been found in animal studies (Ullrich and Storer 1979) and low doses
have been found to increase the latency period for tumor formation in
both normal and cancer prone mice (Mitchel et al. 1999; Mitchel et al.
2003). Low dose-rate studies in animals also strongly support the possi-
bility of dose thresholds (Ullrich and Storer 1979). Recent studies have
implicated immune activation in the suppression of cancer induction in
mice by chronic low dose-rate irradiation (Ina and Sakai 2005a, Ina et al.
2005). In addition, chronic low dose-rate irradiation has been shown to
prolong the lifespan of mice genetically engineered to be susceptible to
multiple severe diseases, again through immunological activation (Ina
and Sakai 2005b).
COMPARISON WITH EPIDEMIOLOGIC FINDINGS 
Dose-response curves for radiation induced cancer in adult humans
can often be equally well fitted with a threshold, a linear-quadratic or a
linear model emphasizing the difficulty in assessing what is really hap-
pening at low doses (≤ 100 mSv) from epidemiologic data. Furthermore,
Transformation, hormesis and risk
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FIGURE 1. Neoplastic transformation frequency as a function of low-LET radiation dose: An analy-
sis of combined data from several independent studies using the human hybrid cell assay. The analy-
ses are stratified by level of spontaneous background into two groups (“low” and high”). For further
detail see Tables 1 and 2. 
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when analyses are performed on incidence of (or mortality from) all solid
cancers, as is often the case for A-bomb survivors, the variability of
response in terms of individual tumor types is obscured. For example,
Preston et al. (2003) have shown differences in mortality risk estimates
for a variety of radiation-induced cancers. While the data for radiation-
induced leukemia in the A-bomb survivors can be fit with a no-threshold
model, it is also not possible to rule out the existence of a threshold in
the range of 100 mSv (Little and Muirhead 1998). Indeed, the low-dose
data from this study are very suggestive of a J-shaped, hormetic-type, dose-
response (see UNSCEAR 2000). The same is true for radiation-induced
breast cancer in humans. The paper on the pooled analysis of eight
cohorts for radiation effects on breast cancer risks represents a valuable
compilation of data for high and low dose-rate exposure (Preston et al.
2002). For doses <100 mGy delivered at high dose-rates, the relative risks
trend, although not significantly so, to values <1. This is even more appar-
ent for low dose-rate exposures where the relative risks are <1 even for
exposures in dose cohorts up to 1000 mGy. Indeed, in one of the original
papers on the low-dose cohorts the authors state that “it was the contri-
bution of subjects with breast doses >1 Gy that produced a positive asso-
ciation between dose and subsequent breast cancer risk” (Lundell et al.
1996). This is but one illustration of a general concern that while epi-
demiologic data can often be fit to a linear no-threshold (LNT) model,
such fitting is often heavily driven by the high dose data points and this
can tend to obscure what is happening at low doses. 
We have previously observed that relative risks for leukemia and breast
cancer incidence and mortality agree well with those determined by our
in vitro transformation assay for intermediate to high dose-rate low-LET
radiation (Redpath et al. 2001). We now have data showing a similar excel-
lent agreement for low dose-rate low-LET radiation when comparing rela-
tive risk for breast cancer incidence with that for neoplastic transforma-
tion in vitro (Elmore et al. 2006). The data indicate that for low to high
dose-rates (1 to 2000 mGy/min) a threshold dose of 100 mGy cannot be
ruled out and that for very low dose-rates (< 0.5 mGy/min) this threshold
could well exceed 500 to 1000 mGy Furthermore, for both endpoints the
existence of a hormetic effect cannot be statistically ruled out. A recent
joint report of the French Academie des Sciences and Academie Nationale
de Medecine also concluded that the LNT model could greatly overesti-
mate the carcinogenic risks associated with low doses (< 100 mGy) of low
LET radiation (Tubiana and Aurengo 2006). On the other hand the
recent report from the U.S. National Academy of Sciences (BEIR VII
PHASE II 2006) concluded that there is no compelling evidence to indi-
cate a dose threshold below which the risk of tumor induction is zero. The
fact that two distinguished committees came to opposite conclusions is
largely a reflection of their differing interpretations of recent biological
J. L. Redpath and E. Elmore
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data, including some of that referred to in this paper. Hopefully, further
research into low-dose effects will eventually resolve this difference. 
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